Inclisiran is a subcutaneously administered synthetic small interfering RNA directed against proprotein convertase subtilisin–kexin type 9, leading to sustained low-density lipoprotein cholesterol ...

FederalRegister.gov retrieves relevant information about this document from Regulations.gov to provide users with additional context. This information is not part of the official Federal Register ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.